Key Financial Data Of Group

Kringle Pharma,Inc. - Filing #7592098

Concept 2021-10-01 to
2022-06-30
2022-04-01 to
2022-06-30
As at
2022-06-30
2020-10-01 to
2021-09-30
As at
2021-09-30
2020-10-01 to
2021-06-30
As at
2021-06-30
2021-04-01 to
2021-06-30
Key financial data of group
Business results of group
Net sales
112,068,000 JPY
289,756,000 JPY
117,825,000 JPY
Ordinary profit (loss)
-305,721,000 JPY
-299,676,000 JPY
-245,177,000 JPY
Net assets
2,713,156,000 JPY
2,506,149,000 JPY
2,557,426,000 JPY
Total assets
3,015,238,000 JPY
2,635,625,000 JPY
2,619,361,000 JPY
Basic earnings (loss) per share
-65.02
2.55
-72.51
-60.13
-12.45
Diluted earnings per share
Equity-to-asset ratio
0.899 xbrli:pure
0.951 xbrli:pure
0.976 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.